Bg pattern

OCTREOTIDE GP-PHARM 0.1 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use OCTREOTIDE GP-PHARM 0.1 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

Octreotide GP-Pharm 0.1 mg/ml Solution for Injection and Infusion EFG

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor, pharmacist, or nurse.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack:

  1. What is Octreotide GP-Pharm and what is it used for
  2. What you need to know before you use Octreotide GP-Pharm
  3. How to use Octreotide GP-Pharm
  4. Possible side effects
  5. Storing Octreotide GP-Pharm
  6. Contents of the pack and other information

1. What is Octreotide GP-Pharm and what is it used for

Octreotide GP-Pharm contains octreotide. This medicine is a synthetic compound derived from somatostatin, a substance that is normally found in the human body that inhibits the effects of some hormones such as growth hormone. The advantages of this medicine compared to somatostatin are that it is more potent and its effects are longer-lasting.

Octreotide GP-Pharm is used

  • for acromegaly, a disease in which the body produces too much growth hormone. Normally, growth hormone controls the growth of tissues, organs, and bones. An excess of growth hormone means an increase in the size of bones and tissues, especially in the hands and feet. This medicine significantly reduces the symptoms of acromegaly, which include headache, excessive sweating, numbness of the hands and feet, fatigue, and joint pain.
  • to relieve symptoms associated with some gastrointestinal tumors(e.g., carcinoid tumors, VIPomas, glucagonomas, gastrinomas, insulinomas, GRFomas). In these diseases, there is an overproduction of certain hormones and other related substances by the stomach, intestine, or pancreas. This overproduction alters the body's natural hormonal balance and produces various symptoms, such as hot flashes, diarrhea, low blood pressure, hives, and weight loss. Treatment with this medicine helps control these symptoms.
  • to prevent complications after pancreatic surgery. Treatment with this medicine helps reduce the possibility of complications after surgery (e.g., abdominal abscesses, pancreatitis).
  • to stop bleeding and protect against repeated bleeding from gastroesophageal varicesin patients with cirrhosis (chronic liver disease). Treatment with this medicine helps control bleeding and reduce the need for transfusions.
  • to treat pituitary tumors that produce too much thyroid-stimulating hormone (TSH). An excess of thyroid-stimulating hormone (TSH) causes hyperthyroidism.

This medicine is used to treat people with pituitary tumors that produce too much thyroid-stimulating hormone (TSH):

  • when other types of treatment (surgery or radiotherapy) are not suitable or have not worked;
  • after radiotherapy, to cover the period until the radiotherapy is fully effective.
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you use Octreotide GP-Pharm

Do not use Octreotide GP-Pharm:

  • If you are allergic to Octreotide or any of the other components of this medicine (listed in section 6)

Warnings and precautions

Consult your doctor before starting treatment with Octreotide GP-Pharm:

  • if you currently have gallstones or have had them in the past or have any complications such as fever, chills, abdominal pain, or yellowing of the skin or eyes; inform your doctor, as prolonged use of Octreotide GP-Pharm may cause gallstones to form. Your doctor may want to check your gallbladder periodically.
  • if you have problems with blood sugar levels, either too high (diabetes) or too low (hypoglycemia). When Octreotide GP-Pharm is used to treat bleeding from gastroesophageal varices, it is mandatory to monitor blood sugar levels.
  • if you have a history of vitamin B12 deficiency, your doctor may monitor your B12 levels periodically.

Octreotide may reduce heart rate and at very high doses may cause an abnormal heart rhythm. Your doctor may monitor your heart rate during treatment.

Tests and checks

If you receive treatment with Octreotide GP-Pharm for a prolonged period, your doctor may periodically check your thyroid function.

Your doctor will check your liver function.

Your doctor may check the functioning of your pancreatic enzymes.

Children

There is limited experience with the use of Octreotide GP-Pharm in children.

Using Octreotide GP-Pharm with other medicines:

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.

Normally, you can continue taking other medicines while being treated with Octreotide GP-Pharm. However, it has been reported that some medicines such as cimetidine, cyclosporine, bromocriptine, quinidine, and terfenadine are affected by Octreotide GP-Pharm.

If you are taking a medicine to control blood pressure (e.g., a beta-blocker or a calcium channel blocker) or an agent to control fluid and electrolyte balance, your doctor may need to adjust the dose.

If you are diabetic, your doctor may need to adjust your insulin dose.

If you are going to receive treatment with lutetium (177Lu) oxodotreotide, a radiopharmaceutical, your doctor may interrupt and/or adapt treatment with Octreotide GP-Pharm.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medicine.

Octreotide GP-Pharm should only be used during pregnancy if it is strictly necessary.

Women of childbearing age must use an effective contraceptive method during treatment.

You should not breastfeed during treatment with Octreotide GP-Pharm. It is unknown whether Octreotide GP-Pharm passes into breast milk.

Driving and using machines

Octreotide GP-Pharm has no effects or negligible effects on the ability to drive or use machines. However, some of these side effects that you may experience during treatment with Octreotide GP-Pharm, such as headache and fatigue, may reduce your ability to drive and use machines safely.

3. How to use Octreotide GP-Pharm

Follow the instructions for administration of this medicine exactly as indicated by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.

Depending on the disease being treated, this medicine is administered by:

  • subcutaneous injection (under the skin) or
  • intravenous infusion (in a vein).

If you have liver cirrhosis (chronic liver disease), your doctor may need to adjust your maintenance dose.

Your doctor or nurse will explain how to inject this medicine under the skin, but infusion into a vein must always be performed by a healthcare professional.

  • Subcutaneous injection

The upper arms, thighs, and abdomen are suitable areas for subcutaneous injection.

A new site should be chosen for each subcutaneous injection to avoid irritating a specific area. Patients who are going to administer the injection themselves should receive specific instructions from their doctor or nurse.

If you keep the medicine in the refrigerator, it is recommended that you let it reach room temperature before using it. This will reduce the risk of pain at the injection site. It can be warmed in the hand, but not heated.

A few patients experience pain at the subcutaneous injection site. This pain usually only lasts for a short time. If this happens to you, you can alleviate it by gently massaging the injection site for a few seconds afterward.

Before using an ampoule of Octreotide GP-Pharm, check for the presence of particles or a change in color. Do not use it if you detect anything abnormal.

If you use more Octreotide GP-Pharm than you should:

Symptoms of overdose are: irregular heartbeat, low blood pressure, cardiac arrest, decreased oxygen supply to the brain, severe pain in the upper abdomen, yellow color of the skin and eyes, nausea, loss of appetite, diarrhea, weakness, fatigue, lack of energy, weight loss, swelling, and abdominal discomfort, high levels of lactic acid in the blood, and abnormal heart rhythm.

If you think you have overdosed and experience any of these symptoms, inform your doctor immediately. You can also call the Toxicology Information Service, phone 91.562.04.20, indicating the medicine and the amount used.

If you forget to use Octreotide GP-Pharm

Administer a dose as soon as you remember and then continue with your usual schedule. It will not harm you to forget a dose, but your symptoms may temporarily recur until you return to your usual treatment schedule.

Do not inject a double dose to make up for forgotten doses.

If you stop treatment with Octreotide GP-Pharm

If you stop your treatment with this medicine, your symptoms may recur. Therefore, do not stop treatment unless your doctor tells you to.

If you have any further questions about the use of this medicine, ask your doctor, nurse, or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Some side effects could be serious. Tell your doctor immediately if you experience any of the following:

Very common(may affect more than 1 in 10 people):

  • Gallstones, which can cause sudden back pain.
  • Too much sugar in the blood.

Common(may affect up to 1 in 10 people):

  • Decreased activity of the thyroid gland (hypothyroidism) that causes changes in heart rate, appetite, or weight; fatigue, feeling cold, or swelling in the front of the neck.
  • Changes in thyroid function tests.
  • Inflammation of the gallbladder (cholecystitis); symptoms may include pain in the upper right abdomen, fever, nausea, yellowing of the skin and eyes (jaundice).
  • Too little sugar in the blood.
  • Alteration of glucose tolerance
  • Slow heart rate.

Uncommon(may affect up to 1 in 100 people):

  • Thirst, low urine output, dark urine, dry reddened skin.
  • Fast heart rate.

Other serious side effects

  • Allergic reactions (hypersensitivity) including skin hives.
  • A type of allergic reaction (anaphylaxis) that can cause difficulty swallowing or breathing, swelling, and tingling, possibly with a decrease in blood pressure with dizziness or loss of consciousness.
  • Inflammation of the pancreas (pancreatitis); symptoms may include sudden pain in the upper abdomen, nausea, vomiting, diarrhea.
  • Inflammation of the liver (hepatitis); symptoms may include yellowing of the skin and eyes (jaundice), nausea, vomiting, loss of appetite, general feeling of discomfort, itching, lightly colored urine.
  • Abnormal heart rhythm.
  • Low platelet count in the blood; this can lead to increased bleeding or bruising.

Tell your doctor immediately if you notice any of the above side effects.

Other side effects:

Tell your doctor, pharmacist, or nurse if you notice any of the following side effects. They are usually mild and tend to disappear as treatment progresses.

Very common(may affect more than 1 in 10 people):

  • Diarrhea.
  • Abdominal pain.
  • Nausea.
  • Constipation.
  • Flatulence (gas).
  • Headache.
  • Local pain at the injection site.

Common(may affect up to 1 in 10 patients):

  • Discomfort in the stomach after eating (dyspepsia).
  • Vomiting.
  • Feeling of having a full stomach.
  • Fatty stools.
  • Watery stools.
  • Change in stool color.
  • Dizziness.
  • Lack of appetite.
  • Changes in liver function tests.
  • Hair loss.
  • Difficulty breathing.
  • Weakness.

If you experience any type of side effect, consult your doctor, nurse, or pharmacist.

A few patients experience pain at the subcutaneous injection site. This pain usually only lasts for a short time. If this happens to you, you can alleviate it by gently massaging the injection site for a few seconds afterward.

If you are administered Octreotide GP-Pharm by subcutaneous injection, you can help reduce the risk of gastrointestinal side effects by avoiding meals near the time of injection. Therefore, it is recommended that you administer Octreotide GP-Pharm between meals or at bedtime.

Reporting side effects

If you experience any side effects, consult your doctor, pharmacist, or nurse, even if they are possible side effects not listed in this leaflet. You can also report them directly through the Spanish Medicines Monitoring System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storing Octreotide GP-Pharm

Keep this medicine out of the sight and reach of children.

Store in a refrigerator (between 2°C and 8°C). Store the ampoules in the outer packaging to protect them from light. For daily use, the medicine can be taken out of the refrigerator and left at room temperature for a few hours before administration, without altering its therapeutic properties.

Do not use this medicine after the expiration date stated on the packaging after EXP. The expiration date is the last day of the month indicated.

Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE collection point in your usual pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.

6. Container Contents and Additional Information

Composition of Octreotida GP-Pharm:

  • The active ingredient is octreotide. Each 1 ml ampoule contains 0.1 mg of octreotide in the form of octreotide acetate.
  • The other components (excipients) are: glycine, water for injectable preparations, hydrochloric acid, and mannitol.

Marketing Authorization Holder and Manufacturer:

GP-Pharm, S.A.

Polígono Industrial Els Vinyets-Els Fogars, sector 2

Carretera comarcal C-244, km 22,

08777 – Sant Quintí de Mediona (Barcelona)

Date of the Last Revision of this Prospectus:January 2025

Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

This information is intended solely for healthcare professionals:

  • Intravenous Infusion (for healthcare professionals)

The ampoules of Octreotida must be stored between 2°C and 8°C. Keep in the original container to protect the product from light.

The single-use ampoules (0.1 mg/ml and 0.5 mg/ml) must be opened immediately before administration, and the unused solution must be discarded.

The contents of an ampoule should normally be dissolved in 50 ml of 0.9% sodium chloride isotonic solution. The solution should be administered using an infusion pump. This should be repeated as necessary until the prescribed treatment duration is reached.

Storage Conditions after Dilution:

The physical and chemical stability of the Octreotida GP-Pharm solution diluted in 0.9% sodium chloride injectable solution and stored in PVC bags is 48 hours when stored at a temperature below 25°C. From a microbiological point of view, the product should be used immediately. If not used immediately, the storage time and conditions are the responsibility of the user and should not normally exceed 24 hours at a temperature between 2°C and 8°C, unless the dilution has taken place under controlled and validated aseptic conditions.

To reduce local discomfort, the injectable solution should be allowed to reach room temperature before administration.

Before using an ampoule of Octreotida GP-Pharm, check if the solution contains particles or if there is a color change. Do not use it if you notice anything abnormal.

How Much Octreotida GP-Pharm to Use

The dose of Octreotida GP-Pharm depends on the disease being treated.

  • Acromegaly

Normally, treatment is initiated at a dose of 0.05 to 0.1 mg every 8 or 12 hours by subcutaneous injection. It is then adjusted according to its effects and symptom relief (such as fatigue, sweating, and headache). In most patients, the optimal daily dose will be 0.1 mg 3 times/day. The maximum dose should not exceed 1.5 mg/day.

  • Gastrointestinal Tract Tumors

Treatment is usually initiated at a dose of 0.05 mg once or twice a day by subcutaneous injection. Depending on the response and tolerability, the dose can be gradually increased to 0.1 mg to 0.2 mg 3 times/day. In carcinoid tumors, treatment should be discontinued if no improvement is observed after 1 week of treatment at the maximum tolerated dose.

  • Complications after Pancreatic Surgery

The usual dose is 0.1 mg 3 times/day by subcutaneous injection for 1 week, starting at least 1 hour before surgery.

  • Gastroesophageal Variceal Bleeding

The recommended dose is 25 micrograms/hour for 5 days by continuous intravenous infusion. Blood sugar level monitoring is necessary during treatment.

  • TSH-Secreting Pituitary Adenomas

The effective dose is usually 100 micrograms three times a day by subcutaneous injection. The dose can be adjusted according to the TSH and thyroid hormone response. At least 5 days are needed to assess efficacy.

Online doctors for OCTREOTIDE GP-PHARM 0.1 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION

Discuss questions about OCTREOTIDE GP-PHARM 0.1 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (43)
Doctor

Dmytro Horobets

Family medicine 7 years exp.

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

  • Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
  • Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
  • Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
  • Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
  • General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
  • Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
  • Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
  • Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

5.0 (78)
Doctor

Lina Travkina

Family medicine 13 years exp.

Dr. Lina Travkina is a licensed family and preventive medicine doctor based in Italy. She provides online consultations for adults and children, supporting patients across all stages of care – from acute symptom management to long-term health monitoring and prevention.

Areas of medical care include:

  • Respiratory conditions: colds, flu, acute and chronic bronchitis, mild to moderate pneumonia, bronchial asthma.
  • ENT and eye conditions: sinusitis, tonsillitis, pharyngitis, otitis, infectious and allergic conjunctivitis.
  • Digestive issues: gastritis, acid reflux (GERD), IBS, dyspepsia, bloating, constipation, diarrhoea, functional bowel symptoms, intestinal infections.
  • Urological and infectious diseases: acute and recurrent cystitis, bladder and kidney infections, prevention of recurrent UTIs, asymptomatic bacteriuria.
  • Chronic conditions: hypertension, diabetes, hypercholesterolemia, metabolic syndrome, thyroid disorders, excess weight.
  • Neurological and general symptoms: headache, migraine, dizziness, fatigue, sleep disturbances, reduced concentration, anxiety, asthenia.
  • Chronic pain support: back, neck, joint, and muscle pain, tension syndromes, pain associated with osteochondrosis and chronic conditions.

Additional care areas:

  • Preventive consultations and check-up planning.
  • Medical advice and follow-up consultations.
  • Test interpretation and diagnostic guidance.
  • Structured support for undiagnosed complaints.
  • Second opinion on diagnoses and treatment plans.
  • Nutritional and lifestyle support for vitamin deficiencies, anaemia, metabolic issues.
  • Post-operative recovery support and pain management.
  • Preconception counselling and postpartum support.
  • Immunity support and strategies to reduce frequency of infections.

Dr. Travkina combines evidence-based medicine with an attentive, personalised approach. Her consultations focus not only on treatment, but also on prevention, recovery, and long-term wellbeing.

If during the consultation it becomes clear that your case requires in-person assessment or specialised care outside of her scope, the session will be terminated and the payment fully refunded.

5.0 (195)
Doctor

Taisiia Proida

Family medicine 7 years exp.

Taisiia Proida is a general practitioner with a specialization in mental health and a cognitive behavioral therapist (CBT), a member of the European Psychiatric Association. She offers online consultations for adults aged 18 and over, combining evidence-based medicine with an individualised approach to mental health care. She specialises in consultations and ongoing support for a wide range of mental health concerns, including: 

  • Mood disorders: depression, bipolar disorder, postpartum depression.
  • Anxiety disorders: generalised anxiety, OCD, panic attacks, phobias.
  • Post-traumatic stress disorder (PTSD) and complex PTSD.
  • Attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Assessment is provided only after an initial psychiatric evaluation and during a follow-up appointment.
  • Personality disorders and emotional instability.
  • Cyclothymia and mood fluctuations.
  • Schizophrenia spectrum and related conditions.

Dr. Proida combines clinical expertise with an empathetic approach, offering structured support based on evidence-based practices. Her work integrates CBT techniques with medical management, with a focus on anxiety and depressive disorders. She works with clients from different countries and cultural backgrounds, adapting her communication style and recommendations to individual needs. With experience in international clinical trials (Pfizer, Merck), she values clarity, trust, and collaborative partnership in patient care.

5.0 (5)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€86
0.0 (0)
Doctor

Joao Silva

General medicine 6 years exp.

Dr. João Silva is a physician with training and experience in the field of General and Family Medicine, dedicated to providing healthcare focused on the well-being and quality of life of his patients. Throughout his professional career, he has developed broad clinical competencies, striving to maintain a medical practice based on scientific evidence and continuous knowledge updates.

Between 2013 and 2019, he completed the Integrated Master's Degree in Medicine at the Abel Salazar Institute of Biomedical Sciences in Porto, where he acquired a solid academic and clinical education.

Subsequently, between January 2021 and December 2021, he completed the General Internship at the Entre Douro e Vouga Hospital Center in Santa Maria da Feira, where he had the opportunity to work in different hospital settings and deepen his competencies in several areas of medicine.

From January 2022 until March 2026, he works as a Resident Physician in General and Family Medicine at USF Salvador Machado in Oliveira de Azeméis, developing clinical activities in primary healthcare, follow-up of chronic patients, and health promotion in the community.

Complementing his medical training, Dr. João Silva also completed a Postgraduate Degree in Continuing and Palliative Care at CESPU, strengthening his preparation in the comprehensive approach to patient care, especially in situations requiring prolonged care and multidisciplinary support.

Camera Book a video appointment
€61
2

Get OCTREOTIDE GP-PHARM 0.1 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION Prescription Online

1

Fill in a 2-min form

Tell us your symptoms, history, and what medicine you're requesting.

2

Pick a doctor or let us assign

Choose a specialist or we'll match you with the next available doctor.

3

Doctor reviews your case

Usually within 30 minutes. They may ask follow-up questions via chat.

4

Collect from any pharmacy

Electronic prescription sent to your email — valid across Spain.

Frequently Asked Questions

Is a prescription required for OCTREOTIDE GP-PHARM 0.1 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION?

OCTREOTIDE GP-PHARM 0.1 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

What is the active substance in OCTREOTIDE GP-PHARM 0.1 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION?

The active ingredient in OCTREOTIDE GP-PHARM 0.1 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION is octreotide. This information helps identify medicines with the same composition but different brand names.

Who manufactures OCTREOTIDE GP-PHARM 0.1 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION?

OCTREOTIDE GP-PHARM 0.1 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION is manufactured by Gp Pharm S.A.. Pharmacy brands and packaging may differ depending on the distributor.

Which doctors can assess the use of OCTREOTIDE GP-PHARM 0.1 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION online?

Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether OCTREOTIDE GP-PHARM 0.1 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

How to buy OCTREOTIDE GP-PHARM 0.1 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION in Spain?

Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.

You can buy OCTREOTIDE GP-PHARM 0.1 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.

To obtain a prescription, you can use Oladoctor:

What are the alternatives to OCTREOTIDE GP-PHARM 0.1 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION?

Other medicines with the same active substance (octreotide) include OCTREOTIDE GP-PHARM 0.5 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION, OCTREOTIDE GP-PHARM 1 mg/5 ml (0.2 mg/ml) INJECTABLE SOLUTION AND PERFUSION SOLUTION, OCTREOTIDE SUN 100 micrograms/ml Injectable Solution. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media